Klotho Neurosciences, Inc.
KLTO
$0.48
$0.049.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 29.26% | -83.22% | -8.06% | 30.14% | -555.31% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.04% | 125.52% | 40.64% | -57.41% | 4,679.50% |
| Change in Net Operating Assets | 105.81% | 1.57% | -250.50% | 1,316.14% | 94.88% |
| Cash from Operations | 44.72% | -26.69% | -64.55% | 12.00% | -18.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -98.64% | 77.20% | 343.33% | -71.58% |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -99.96% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 315.64% | 45.67% | -1,511.76% | -98.90% |
| Cash from Financing | -99.95% | 378.31% | 114.83% | 243.63% | -83.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -113.77% | 1,466.44% | 3,822.66% | 101.61% | -197.71% |